Ahlstrom grants President and CEO Marco Levi, who started his new position on June 16, total of 120,000 company shares as part of long-term share-based incentive plan, which was authorized at AGM on March 25

HELSINKI , June 16, 2014 (press release) – Ahlstrom Corporation's President and CEO Marco Levi has started in his new position today, on June 16, 2014.

The Board of Directors of Ahlstrom has on June 15, 2014 decided to grant Marco Levi a total of 120,000 company shares based on the authorization by the Annual General Meeting on March 25, 2014 to distribute the company's own shares. The shares are part of the long-term share-based incentive plan of the President and CEO and are granted free of charge on terms typical for so-called restricted shares.

The shares will be subscribed and granted on August 31, 2014 at the latest. The ownership of the retention shares includes restrictions such as the right to gradually transfer and dispose of the shares only after 2-4 years and the company's right to buy back the shares.

More details on the remuneration of the President and CEO are available on Ahlstrom's web pages at www.ahlstrom.com/en/Investors/Corporate-governance.

Ahlstrom in brief
Ahlstrom is a high performance fiber-based materials company, partnering with leading businesses around the world to help them stay ahead. We aim to grow with a product offering for clean and healthy environment. Our materials are used in everyday applications such as filters, medical fabrics, life science and diagnostics, wallcoverings and food packaging. In 2013, Ahlstrom's net sales from the continuing operations amounted to EUR 1 billion. Our 3,500 employees serve customers in 24 countries. Ahlstrom's share is quoted on the NASDAQ OMX Helsinki. More information available at www.ahlstrom.com.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.